Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation

American Journal of Surgical Pathology

Volumn 35, Issue 8, 2011, Pages 1214-1225

  Garcia Herrera, Adriana ^a   Song, Joo Y ^d   Chuang, Shih Sung ^e   Villamor, Neus ^a   Colomo, Luis ^a   Pittaluga, Stefania ^d   Alvaro, Tomas ^c   Rozman, Maria ^a   De Anda Gonzalez, Jazmin ^f   Arrunategui, Ana Maria ^g   Fernandez, Eva ^a   Gonzalvo, Elena ^a   Estrach, Teresa ^b   Colomer, Dolors ^a   Raffeld, Mark ^d   Gaulard, Philippe ^h   Campo, Elias ^a   Jaffe, Elaine S ^d   Martinez, Antonio ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL VERGE DE LA CINTA   (Spain)

^d NATIONAL CANCER INSTITUTE   (United States)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^g FUNDACIÓN VALLE DEL LILI   (Colombia)

^h HENRI MONDOR HOSPITAL   (France)

Author keywords

T cell receptor; T cell lymphomas; T cell receptor; cutaneous T cell lymphoma; hepatosplenic T cell lymphoma

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR; PARAFFIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CUTANEOUS T CELL LYMPHOMA; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE REARRANGEMENT; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; SKIN TUMOR; T CELL LYMPHOMA; T LYMPHOCYTE RECEPTOR GENE;

ADOLESCENT; ADULT; AGED; FEMALE; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; GENES, T-CELL RECEPTOR GAMMA; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LYMPHOMA, T-CELL; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SKIN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; YOUNG ADULT;

EID: 79961077697     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31822067d1     Document Type: Article

References (38)

1. Akiyama T, Okino T, Konishi H, et al. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients. Pathol Int. 2008;58:626-634.
2. Arnulf B, Copie-Bergman C, Delfau-Larue MH, et al. Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood. 1998;91: 1723-1731. (Pubitemid 28110338)
3. Balague O, Martinez A, Colomo L, et al. Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features. Am J Surg Pathol. 2007;31:1310-1322. (Pubitemid 47329666)
4. Bartl S, Baltimore D, Weissman IL. Molecular evolution of the vertebrate immune system. Proc Natl Acad Sci U S A. 1994;91: 10769-10770. (Pubitemid 24349566)
5. Belhadj K, Reyes F, Farcet JP, et al. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood. 2003;102:4261-4269. (Pubitemid 37494082)
6. Borst J, van Dongen JJ, Bolhuis RL, et al. Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody. J Exp Med. 1988;167:1625-1644.
7. Carding SR, Egan PJ. Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol. 2002;2:336-345. (Pubitemid 37328756)
8. Chien YH, Jores R, Crowley MP. Recognition by gamma/delta T cells. Annu Rev Immunol. 1996;14:511-532.
9. Chott A, Vesely M, Simonitsch I, et al. Classification of intestinal T-cell neoplasms and their differential diagnosis. Am J Clin Pathol. 1999;111:S68-S74. (Pubitemid 29024951)
10. Chuang SS, Chang ST, Chuang WY, et al. NK-cell lineage predicts poor survival in primary intestinal NK-cell and T-cell lymphomas. Am J Surg Pathol. 2009;33:1230-1240.
11. Cooke CB, Krenacs L, Stetler-Stevenson M, et al. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood. 1996;88:4265-4274. (Pubitemid 26399174)
12. de Wolf-Peeters C, Achten R. gammadelta T-cell lymphomas: a homogeneous entity? Histopathology. 2000;36:294-305. (Pubitemid 30198911)
13. Deusch K, Luling F, Reich K, et al. A major fraction of human intraepithelial lymphocytes simultaneously expresses the gamma/ delta T cell receptor, the CD8 accessory molecule and preferentially uses the V delta 1 gene segment. Eur J Immunol. 1991;21:1053-1059.
14. Dippel E, Assaf C, Hummel M, et al. Clonal T-cell receptor gammachain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation. J Pathol. 1999;188:146-154. (Pubitemid 29253933)
15. Dojcinov SD, Venkataraman G, Raffeld M, et al. EBV positive mucocutaneous ulcerFa study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010;34:405-417.
16. Ebert LM, Meuter S, Moser B. Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance. J Immunol. 2006;176:4331-4336. (Pubitemid 44264412)
17. Falini B, Flenghi L, Pileri S, et al. Distribution of T cells bearing different forms of the T cell receptor gamma/delta in normal and pathological human tissues. J Immunol. 1989;143:2480-2488. (Pubitemid 19260052)
18. Farcet JP, Gaulard P, Marolleau JP, et al. Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood. 1990;75:2213-2219. (Pubitemid 20181173)
19. Garcia-Herrera A, Colomo L, Camos M, et al. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome. J Clin Oncol. 2008;26:3364-3371.
20. Gaulard P, Bourquelot P, Kanavaros P, et al. Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/ delta T-cell lymphomas. Am J Pathol. 1990;137:617-628. (Pubitemid 20280991)
21. Goodman T, Lefrancois L. Expression of the gamma-delta T-cell receptor on intestinal CD8+ intraepithelial lymphocytes. Nature. 1988;333:855-858.
22. Groh V, Porcelli S, Fabbi M, et al. Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system. J Exp Med. 1989;169: 1277-1294. (Pubitemid 19104962)
23. Haas W, Pereira P, Tonegawa S. Gamma/delta cells. Annu Rev Immunol. 1993;11:637-685. (Pubitemid 23115020)
24. Hayday AC. [gamma][delta] cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol. 2000;18: 975-1026. (Pubitemid 30365402)
25. Huang Y, de RA, de LL, et al. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. Blood. 2010;115:1226-1237.
26. Jaffe ES, Krenacs L, Raffeld M. Classification of cytotoxic T-cell and natural killer cell lymphomas. Semin Hematol. 2003;40: 175-184. (Pubitemid 36842595)
27. Jameson J, Ugarte K, Chen N, et al. A role for skin gammadelta T cells in wound repair. Science. 2002;296:747-749. (Pubitemid 34442005)
28. Janeway CA Jr, Jones B, Hayday A. Specificity and function of T cells bearing gamma delta receptors. Immunol Today. 1988;9: 73-76. (Pubitemid 18053714)
29. Macon WR, Salhany KE. T-cell subset analysis of peripheral T-cell lymphomas by paraffin section immunohistology and correlation of CD4/CD8 results with flow cytometry. Am J Clin Pathol. 1998;109: 610-617. (Pubitemid 28191551)
30. Mansoor A, Pittaluga S, Beck PL, et al. NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood. 2011;117:1447-1452.
31. Roullet M, Gheith SM, Mauger J, et al. Percentage of (gamma) (delta) T cells in panniculitis by paraffin immunohistochemical analysis. Am J Clin Pathol. 2009;131:820-826.
32. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008.
33. Takeuchi K, Yokoyama M, Ishizawa S, et al. Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood. 2010;116:5631-5637.
34. Tjon JM, Verbeek WH, Kooy-Winkelaar YM, et al. Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor-CD3 expression in enteropathy-associated T-cell lymphoma. Blood. 2008;112:5103-5110.
35. Toro JR, Beaty M, Sorbara L, et al. gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study. Arch Dermatol. 2000;136:1024-1032. (Pubitemid 30629130)
36. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317. (Pubitemid 38072572)
37. Vega F, Medeiros LJ, Gaulard P. Hepatosplenic and other gammadelta T-cell lymphomas. Am J Clin Pathol. 2007;127: 869-880.
38. Willemze R, Jansen PM, Cerroni L, et al. Subcutaneous panniculitis- like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood. 2008;111:838-845.